Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bill Ackman to Sell Shares in Pershing Square

Bill Ackman, founder of Pershing Square Capital Management, announced yesterday evening that he is planning to sell shares in his prominent hedge fund in order to generate capital for more investments. He told an audience at the Harmonie Club in New York that the shares are expected to be made available in early 2012. When asked for his reasoning, Ackman explained that current “prices assume financial Armageddon”, but it is more likely that he has learned from his mistakes.

Bill Ackman in front of Perishi

In 2009, his Pershing Square lost around 27% of its capital when investors opted to pull out. By listing shares in his fund, Ackman doesn’t “have to worry about investors pulling cash redemptions,” explained BusinessWeek on Wednesday. “Closed-end funds raise capital by selling a set amount of shares through an initial public offering, then trade on an exchange like a stock. The price can fluctuate above or below the value of the underlying holdings.”

Ackman was very careful however to explain that Pershing Square would not be going public.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!